Dynamics of clinical symptoms of fibrocystic breast disease in the course of the transdermal gel of micronized progesterone monotherapy: results of the Russian multicenter observational study BREAST
- Autores: Protasova A.E.1,2,3, Andreyeva E.N.4,5, Rozhkova N.I.6, Vandeyeva E.N.3
-
Afiliações:
- Saint Petersburg State University
- North-Western State Medical University named after I.I. Mechnikov
- Almazov National Medical Scientific Center of the Ministry of Health the Russian Federation
- National Scientific Endocrinological Center of the Ministry of Health the Russian Federation
- Moscow State University of Medicine and Dentistry named after A.I.Evdokimov
- Gertsen National Center of reproductive oncology of the Ministry of Health the Russian Federation
- Edição: Nº 11 (2018)
- Páginas: 137-144
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248370
- DOI: https://doi.org/10.18565/aig.2018.11.138-134
- ID: 248370
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
Anna Protasova
Saint Petersburg State University; North-Western State Medical University named after I.I. Mechnikov; Almazov National Medical Scientific Center of the Ministry of Health the Russian Federation
Email: protasoval966@yandex.ru
Professor of the Department of Obstetrics and Gynecology
Elena Andreyeva
National Scientific Endocrinological Center of the Ministry of Health the Russian Federation; Moscow State University of Medicine and Dentistry named after A.I.Evdokimov
Email: endogen@mail.ru
Professor, Head of the Institute of Reproductive Medicine
Nadezhda Rozhkova
Gertsen National Center of reproductive oncology of the Ministry of Health the Russian Federation
Email: nrozhkova20l3@yandex.ru
Professor, Head
Ekaterina Vandeyeva
Almazov National Medical Scientific Center of the Ministry of Health the Russian Federation
Email: katvanl983@mail.ru
Junior assistant of the Department of Obstetrics and Gynecology
Bibliografia
- Кулагина Н.В. Доброкачественные заболевания молочных желез. Учебное пособие. 2-е изд. М.: «Типография «Печатных дел мастер»; 2012. 64с.
- Коган И.Ю., Мясникова М.О., Мусина Е.В. Прогестерон в лечении мастопатии. Айламазян Э.К. ред. М.: «Типография «Печатных дел мастер»; 2012.
- Сметник В.П., Коновалова В.Н. Молочная железа как своеобразный" интракринный орган. Вестник репродуктивного здоровья. 2009; 1: 39-44.
- Jameson J.L., De Groot L.J., de Kretser D.M., Giudice L.C., Grossman A.B., Melmed S. et al., eds. Endocrinology: adult and pediatric. 7th ed. Philadelphia PA USA: Elsevier; 2016; vol. 2(Pt 12: Hormonal control of breast development).
- NCCN - Evidence-Based Cancer Guidelines. https://www.nccn.org/
- Onstad M., Stuckey A., Benign breast disorders. Obstet Gynecol Clin North Am. 2013; 40 (3): 459-473.
- Dyrstad S.W., Yan Y., Fowler A.M., Colditz G.A. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res. Treat. 2015; 149(3): 569-75.
- Mansel RE, Webster DJ, Sweetland HM. Breast pain and nodularity. In: Benign disorders and diseases of the breast. Elsevier 2009; p. 107-39.
- Андреева Е.Н., Рожкова Н.И., Соколова Д.А., ред. Доброкачественные дисплазии молочных желез: патогенетический вектор лечения. Обзор исследовании! клинические рекомендации: Информационный бюллетень. М.: StatusPraesens; 2016.
- Высоцкая И.В., Летягин В.П., Черенков В.Г., Лактионов К.П., Бубликов И.Д. Клинические рекомендации РООМ по профилактике РМЖ, дифференциальной диагностике, лечению предопухолевых и доброкачественных заболевании" молочных желез. М.: Российское общество онкомаммологов; 2015.
- Меских Е.В., Рожкова Н.И. Применение прожестожеля при диффузных формах мастопатии. Опухоли женскои" репродуктивнои" системы. 2012; 1: 57-60.
- Каприн А.Д., Рожкова Н.И. Маммология. Национальное руководство, М., ГЭОТАР Медиа; 2016: 483.
- Fentiman I.S. The pathophysiology and therapy of benign breast disease. In: Fauser B.C. ed. Reproductive medicine: molecular, cellular and genetic fundamentals. Pathenon Publ.; 2003: 87-94.
- Brkic M., Vujovic S., Ivanisevic M.F., Ivovic M., Gajic M.T., Marina L. et al. The influence of progesterone gel therapy in the treatment of fibrocystic breast disease. Open J. Obstet. Gynecol. 2016; 6(5): 334-41.
- Pasqualini J.R. Differential effects of progestins on breast tissue enzy- mes. Maturitas 2003; 46 (Suppl. l): S45-54.
- Winkler U.H., Schindler A.E., Brinkmann U.S., Ebert C., Oberhoff C. Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecol Endocrinol. 2001 Dec;15 Suppl 6:37-43.